

share
Exbivirumab CAS NO 569658-80-6
Unit Price:
CAS No.:569658-80-6
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Exbivirumab is a high-purity monoclonal antibody (mAb) compound, identified by CAS number 569658-80-6, designed for advanced research and development applications. This product is critical for pharmaceutical and biotechnological studies requiring precise biological activity and specificity. It is primarily utilized by researchers and manufacturers in the biopharmaceutical sector for drug discovery, therapeutic development, and immunological assays.
Application
- Primary candidate for therapeutic monoclonal antibody research and development.
- Key reagent in immunological and cell-based assays for target validation.
- Use in preclinical studies for evaluating pharmacokinetics and efficacy.
- Critical component in the development of biosimilar or biobetter candidates.
- Tool compound for studying specific antigen-antibody interactions and signaling pathways.
- Potential use in diagnostic kit development and biomarker detection.
Basic Information
| Product Name | Exbivirumab |
| CAS No. | 569658-80-6 |
| Molecular Formula | Contact for details |
| Molecular Weight | Contact for details |
| Synonyms | Anti-IL-17A/F Recombinant Antibody; IL-17A/F Inhibitor; BIM-22914; Recombinant Humanized Anti-IL17A/F Monoclonal Antibody; CA-18H3; CA 18H3; CA18H3 |
| EINECS | Contact for details |
Quality Control
Our Exbivirumab is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including purity assessment by HPLC, identity confirmation, and biological activity assays to ensure it meets the high standards required for research and development. Certificates of Analysis (COA) detailing all specifications are available upon request.
Storage
Preserve in a tightly closed container, protected from light. Store at 2-8°C for long-term stability. This product is hygroscopic (moisture-sensitive) and should be handled under appropriate conditions to prevent degradation. For specific storage and handling protocols, refer to the material safety data sheet.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white lyophilized powder or clear solution |
| Identification (HPLC/MS) | Conforms to reference standard |
| Purity (HPLC) | ≥ 95.0% |
| Protein Content (UV) | Contact for details |
| Endotoxin (LAL) | < 1.0 EU/mg |
| Biological Activity (Cell-based assay) | Contact for details |
| Solubility | Soluble in appropriate aqueous buffers |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Pembrolizumab CAS NO 1374853-91-4


Tuvirumab CAS NO 138660-97-6


Biciromab CAS NO 138783-13-8


Muromonab-Cd3 CAS NO 140608-64-6


Anti-Stromelysin-2 CAS NO 140610-48-6


Gendevit CAS NO 141910-80-7


Edrecolomab CAS NO 156586-89-9


Felvizumab CAS NO 167747-20-8


Faralimomab CAS NO 167816-91-3


Rovelizumab [Usan:Inn] CAS NO 197099-66-4


Teprotumumab CAS NO 1036734-93-6


Monalizumab CAS NO 1228763-95-8


Anifrolumab CAS NO 1326232-46-5


Anti-Br140-Like Protein Antibody Produced In Rabbit CAS NO 1597439-92-3


Eptinezumab CAS NO 1644539-04-7


Rhumab Cd 168 CAS NO 211323-03-4


Ociperlimab CAS NO 2342597-93-5


Tadocizumab CAS NO 339086-80-5


Galiximab CAS NO 357613-77-5


Tocilizumab CAS NO 375823-41-9
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






